Medpace Holdings, Inc. — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d83daaa2-14d8-4e81-9b46-d8e22f72ce79/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $2.5B | 2025-01-01 – 2025-12-31 | evidence 0001668397-26-000006 |
| FY 2024 | $2.1B | 2024-01-01 – 2024-12-31 | evidence 0001668397-25-000017 |
| FY 2023 | $1.9B | 2023-01-01 – 2023-12-31 | evidence 0001668397-24-000013 |
| FY 2022 | $1.5B | 2022-01-01 – 2022-12-31 | evidence 0001668397-23-000008 |
| FY 2021 | $1.1B | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-001280 |
| FY 2020 | $925.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-006072 |
| FY 2019 | $861.0M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-006385 |
| FY 2018 | $704.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004451 |
| FY 2017 | $436.2M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-004451 |
| FY 2016 | $421.6M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-004451 |
| FY 2015 | $359.1M | 2015-01-01 – 2015-12-31 | evidence 0001564590-17-002839 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Medpace Holdings, Inc. — all facts · Net Income · Operating Income